FDA Inspection 1231931 — Amoli Organics (A Division of Umedica Laboratories Pvt Ltd)

Amoli Organics (A Division of Umedica Laboratories Pvt Ltd) — FEI 3004810446

The FDA completed an inspection of Amoli Organics (A Division of Umedica Laboratories Pvt Ltd) on March 4, 2024 in Vapi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 4, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vapi (India)